Performance and microbial shift during acidification of a real pharmaceutical wastewater by using an anaerobic sequencing batch reactor (AnSBR)

Optimization of sulfate reduction and methanogenesis via phase separation in a two-phase internal circulation reactor for the treatment of high-sulfate organic wastewater

To enhance the performance of the internal circulation (IC) reactor when treating high-sulfate organic wastewater, a laboratory-scale two-phase IC reactor with distinct phase separation capabilities was designed, and the sulfate reduction and methanogenesis processes were optimized by segregating the reactor into two specialized reaction zones. The results demonstrated that the first and second reaction areas of the two-phase IC reactor could be maintained at 4.5-6.0 and 7.5-8.5, respectively, turning them into the specialized phase for sulfate reduction and methanogenesis. Through phase separation, the two-phase IC reactor achieved a COD degradation and sulfate reduction efficiency of more than 80% when the influent sulfate concentration exceeded 5,000 mg/L, which were 32.32% and 16.04% higher than that before phase separation. Functional analyses indicated a greater activity of both the dissimilatory and assimilatory sulfate reduction pathways in the acidogenic phase, largely due to a rise in the relative abundance of the genera Desulfovibrio, Bacteroides, and Lacticaseibacillus, the primary carriers of sulfate reduction functional genes. In contrast, all the acetoclastic, hydrogenotrophic, and methylotrophic methanogenesis pathways were inhibited in the acidogenic phase but thrived in the methanogenic phase, coinciding with shifts in the genus Methanothrix, which harbors the mcrA, mcrB, and mcrG genes essential for the final transformation step of all three methanogenesis pathways.

Comparative overview of advanced oxidation processes and biological approaches for the removal pharmaceuticals

Nowadays, pharmaceuticals are the center of significant environmental research due to their complex and highly stable bioactivity, increasing concentration in the water streams and high persistence in aquatic environments. Conventional wastewater treatment techniques are generally inadequate to remove these pollutants. Aiming to tackle this issue effectively, various methods have been developed and investigated on the light of chemical, physical and biological procedures. Increasing attention has recently been paid to the advanced oxidation processes (AOPs) as efficient methods for the complete mineralization of pharmaceuticals. Their high operating costs compared to other processes, however, remain a challenge. Hence, this review summarizes the current and state of art related to AOPs, biological treatment and their effective exploitation for the degradation of various pharmaceuticals and other emerging molecules present in wastewater. The review covers the last decade with a particular focus on the previous five years. It is further envisioned that this review of advanced oxidation methods and biological treatments, discussed herein, will help readers to better understand the mechanisms and limitations of these methods for the removal of pharmaceuticals from the environment. In addition, we compared AOPs and biological treatments for the disposal of pharmaceuticals from the point of view of cost, effectiveness, and popularity of their use. The exploitation of coupling AOPs and biological procedures for the degradation of pharmaceuticals in wastewater was also presented. It is worthy of note that an integrated AOPs/biological system is essential to reach the complete degradation of pharmaceuticals; other advantages of this hybrid technique involve low energy cost, an efficient degradation process and generation of non-toxic by-products.

Is sequential batch reactor an efficient technology to protect recipient against non-steroidal anti-inflammatory drugs and paracetamol in treated wastewater?

The tested facility was a wastewater treatment plant (WWTP) in Swarzewo, where the wastewater treatment takes place in aeration chambers with activated sludge using sequential batch reactors (SBRs). The concentration of the following pharmaceuticals: ibuprofen, paracetamol, flurbiprofen, naproxen, diclofenac, and its metabolites 5OH-diclofenac and 4OH-diclofenac was tested in influents and effluents. Simultaneously, the conventional parameters were characterised. The removal of conventional pollutants was high (94.4-99.5%). At the same time, the removal of pharmaceuticals was variable. In the case of diclofenac and its metabolites, the concentration in the effluent was higher than in the influents. The risk quotients (RQs) calculated for analyzed pharmaceuticals suggest low environmental risk for selected species. However, negative impact for the biota due to the chronic presence of diclofenac cannot be excluded. It can be concluded that the SBRs, similarly to traditional flow activated sludge technology, are not efficient in the removal of target pharmaceuticals.